We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBE SCIENTIFIC, LLC

Download Mobile App




New Robotic System Automates Clinical Flow Cytometry Diagnostics

By LabMedica International staff writers
Posted on 14 Jun 2023

Flow cytometry analyzes a population of cells on a cell-by-cell basis, an essential feature for researchers and clinicians aiming to identify specific cells within a sample for disease or biological process studies. More...

This technique is not only extraordinarily rapid, but it also enables the simultaneous measurement of multiple attributes of single cells, a process known as multiplexing. These benefits have transformed flow cytometry into a versatile tool for both researchers and clinicians, making it a critical instrument for clinical diagnostics, especially in diagnosing and managing diseases like cancer. Now, a new automated instrument that prepares samples for clinical diagnostics using flow cytometry offers a full "walkaway" workflow solution to enhance standardization and reproducibility in cellular diagnostics.

BD (Becton, Dickinson and Company, Franklin Lakes, NJ, USA) has launched the new BD FACSDuet Premium Sample Preparation System globally. This system employs liquid-handling robotics to fully automate the sample preparation process for both in vitro diagnostics (IVD) and user-defined tests. It handles tasks such as cocktailing, washing, and centrifuging, and then automatically transfers samples to the physically integrated BD FACSLyric Clinical Flow Cytometry System, eliminating the need for human intervention. Thanks to its integration with the flow cytometer, the BD FACSDuet Premium System offers a "walkaway" workflow solution that cuts down manual steps, resources, and user hands-on time compared to previous solutions.

"Our clinical customers have long trusted BD and our best-in-class products to standardize every step of the clinical lab workflow – from panel creation to sample preparation to analysis to report," said Steve Conly, worldwide president, BD Biosciences. "The flagship BD FACSLyric Flow Cytometry System is one of the fastest adopted clinical instruments in the world and now together with the FACSDuet Premium System, which has achieved IVD status in the U.S. and Europe, we usher in greater levels of automation so that our customers can focus more of their valuable time on analyzing and interpreting samples and impacting outcomes."

Related Links:
BD


New
Gold Member
Latex Test
SLE-Latex Test
Serological Pipet Controller
PIPETBOY GENIUS
New
PlGF Test
Quidel Triage PlGF Test
New
Automated PCR Setup
ESTREAM
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more

Pathology

view channel
These images illustrate how precision oncology Organ Chips recapitulate individual patients’ responses to chemotherapy (Photo courtesy of Wyss Institute at Harvard University)

Cancer Chip Accurately Predicts Patient-Specific Chemotherapy Response

Esophageal adenocarcinoma (EAC), one of the two primary types of esophageal cancer, ranks as the sixth leading cause of cancer-related deaths worldwide and currently lacks effective targeted therapies.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.